Company Data
Genenta Science S.p.A.
Ticker
GNTA
Current Price
$0.9101 -1.31%
Market Cap
$21.3M
Price Target
Refer to Report
Volume
38.5K
52wk Range
$0.705 - $10
Overview
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company’s product under development includes Temferon – a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.